Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-01-27 @ 9:34 PM
Study NCT ID:
NCT04084366
Status:
TERMINATED
Last Update Posted:
2025-03-26
First Post:
2019-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors
Sponsor:
OBI Pharma, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-05
First Submit QC Date:
None
Study First Post Date:
2019-09-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-05
Results First Submit QC Date:
None
Results First Post Date:
2025-03-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-25
Last Update Post Date:
2025-03-26
Last Update Post Date Type:
ACTUAL